These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37885547)

  • 1. The Synergistic Relationship Between Atrial Fibrillation and Diabetes Mellitus: Implications for Cardiovascular and Metabolic Health.
    Mohsin M; Zeyad H; Khalid H; Gapizov A; Bibi R; Kamani YG; Rashid A; Shams M; Khalid F; Khan S; Waqas M; Ishfaq A; Kebede AH; Subhan M
    Cureus; 2023 Sep; 15(9):e45881. PubMed ID: 37885547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment.
    Leopoulou M; Theofilis P; Kordalis A; Papageorgiou N; Sagris M; Oikonomou E; Tousoulis D
    World J Diabetes; 2023 May; 14(5):512-527. PubMed ID: 37273256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.
    Papazoglou AS; Kartas A; Moysidis DV; Tsagkaris C; Papadakos SP; Bekiaridou A; Samaras A; Karagiannidis E; Papadakis M; Giannakoulas G
    Cardiovasc Diabetol; 2022 Mar; 21(1):39. PubMed ID: 35287684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
    Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
    Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus.
    Fauchier L; Boriani G; de Groot JR; Kreutz R; Rossing P; Camm AJ
    Europace; 2021 Dec; 23(12):1873-1891. PubMed ID: 34411235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation.
    Soran H; Banerjee M; Mohamad JB; Adam S; Ho JH; Ismaeel SM; Dhage S; Syed AA; Abdulla IMA; Younis N; Malik RA
    Biomed Res Int; 2018; 2018():5936180. PubMed ID: 29721508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Epidemiology of Atrial Fibrillation in Nigeria: A Focus on Atrial Fibrillation in Heart Failure Patients and Its Association With Stroke.
    Otabor EO; Alaka A; Onwuzo CN; Olukorode J; Fagbenro A; Ajiboye A
    Cureus; 2024 Feb; 16(2):e55241. PubMed ID: 38558636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukins in pathogenesis and prognosis of atrial fibrillation.
    Lotfi ME; Pezeshki PS; Rezaei N
    Expert Rev Clin Immunol; 2023 Jun; 19(6):585-597. PubMed ID: 36964672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex interplay between diabetes mellitus and atrial fibrillation.
    Yildiz M; Lavie CJ; Morin DP; Oktay AA
    Expert Rev Cardiovasc Ther; 2022 Sep; 20(9):707-717. PubMed ID: 35984314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies.
    Goudis CA; Korantzopoulos P; Ntalas IV; Kallergis EM; Liu T; Ketikoglou DG
    Int J Cardiol; 2015 Apr; 184():617-622. PubMed ID: 25770841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation for atrial fibrillation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpharmacologic strategies for treating atrial fibrillation.
    Lüderitz B; Pfeiffer D; Tebbenjohanns J; Jung W
    Am J Cardiol; 1996 Jan; 77(3):45A-52A. PubMed ID: 8607391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights.
    Bohne LJ; Johnson D; Rose RA; Wilton SB; Gillis AM
    Front Physiol; 2019; 10():135. PubMed ID: 30863315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).
    Fatemi O; Yuriditsky E; Tsioufis C; Tsachris D; Morgan T; Basile J; Bigger T; Cushman W; Goff D; Soliman EZ; Thomas A; Papademetriou V
    Am J Cardiol; 2014 Oct; 114(8):1217-22. PubMed ID: 25159234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.
    Asghar O; Alam U; Hayat SA; Aghamohammadzadeh R; Heagerty AM; Malik RA
    Curr Cardiol Rev; 2012 Nov; 8(4):253-64. PubMed ID: 22920475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metformin on outcomes of catheter ablation for atrial fibrillation.
    Deshmukh A; Ghannam M; Liang J; Saeed M; Cunnane R; Ghanbari H; Latchamsetty R; Crawford T; Batul SA; Chung E; Bogun F; Jongnarangsin K; Pelosi F; Chugh A; Morady F; Oral E; Oral H
    J Cardiovasc Electrophysiol; 2021 May; 32(5):1232-1239. PubMed ID: 33600005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.